of December 27, 2023 No. 190
About the termination of consideration of the case about availability of violation of general competition rules in the cross-border markets
The board of the Eurasian economic commission according to subitems 3 and 4 of Item 10 of the Protocol on the general principles and competition rules (appendix No. 19 to the Agreement on the Eurasian Economic Union of May 29, 2014), Items 44 and 45 of the Procedure for the hearing of cases on violation of general competition rules in the cross-border markets approved by the Decision of Council of the Eurasian economic commission of November 23, 2012 No. 99, considered question of violation of general competition rules in the cross-border markets on the case of violation of general competition rules in the cross-border markets of the Sodium Heparin medicine made by the republican unitary enterprise of Belmedpreparata (The Republic of Belarus, Minsk, Ulitsa Fabritsiusa, 30, RN 100049731, registration date - on July 2, 2004, UNP 100049731) (further - RUP of Belmedpreparata) and delivered to them to business entities (subjects of the market) of state members of the Eurasian Economic Union within primary realization (primary input by the producer in civil circulation) (further - case).
Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info
Database include more 50000 documents. You can find needed documents using search system. For effective work you can mix any on documents parameters: country, documents type, date range, teams or tags.
More about search system
If you cannot find the required document, or you do not know where to begin, go to Help section.
In this section, we’ve tried to describe in detail the features and capabilities of the system, as well as the most effective techniques for working with the database.
You also may open the section Frequently asked questions. This section provides answers to questions set by users.